大动脉狭窄的现象和精确的跨导管大动脉植入
Muzamil Khawaja1, Hafeez Ul Hassan Virk2, Dhrubajyoti Bandyopadhyay3
1Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Journal of cardiovascular development and disease
|July 28, 2023
概括
过导管大动脉植入 (TAVI) 为大动脉置换提供了一个微创的选择. 由于大动脉狭窄表型,TAVI后患者的结果可能会有所不同,这表明在患者选择和管理中需要精准医学.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 遗传学 是一个遗传学.
背景情况:
- 大动脉置换适用于大动脉狭窄的患者,其中包括手术大动脉置换 (SAVR) 和透气管大动脉植入 (TAVI) 等选择.
- 由于其微创性质,TAVI越来越多地被考虑,但可变的临床结果 (死亡,中风,心血管事件) 需要进一步调查.
- 影响TAVI结果的因素包括大动脉狭窄病因,患者的并发症,以及不断发展的医疗疗法和设备.
研究的目的:
- 研究大动脉狭窄现象对经过过导管大动脉植入术 (TAVI) 后临床结果的影响.
- 为TAVI程序中患者选择和管理提出精准医学方法.
主要方法:
- 文献审查和对TAVI结果现有数据的分析.
- 探索患者的并发症,环境因素,固有的风险和大动脉狭窄病理学中的遗传学之间的相互作用.
- 假设表型变异在TAVI结果中的重要作用.
主要成果:
- 在各种终点中观察到TAVI结果的差异.
- 大动脉狭窄的表型变异,受并发症和风险因素的影响,被认为是TAVI后临床结果的主要决定因素.
- 新出现的证据表明,患者遗传在大动脉狭窄病理学中的潜在作用.
结论:
- 大动脉狭窄的表型变化显著影响TAVI后的临床结果.
- 建议采用精准医学方法,考虑遗传和表型因素,以优化TAVI患者的选择和管理.
更多相关视频
相关概念视频
Mitral Stenosis III: Medical Management
13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Mitral Stenosis II: Clinical features and Diagnostic Tests
23
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
23
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
27
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
27
Mitral Stenosis I: Introduction
18
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18
Aortic Regurgitation I: Introduction
13
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
13
Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25


